Health & Fitness
Baby Formula Recalled In PA Due To Improperly Sealed Bottles: FDA
Baby formula manufacturer Abbott is recalling several of its liquid bottle products sold in the U.S., including in PA. Here's what to know.

PENNSYLVANIA - Baby formula manufacturer Abbott is recalling several types of its liquid bottle products sold in the U.S., including in Pennsylvania, according to federal officials.
The recall is in effect as a small percentage of bottles (less than 1%) have bottle caps that may not have been sealed properly, which could result in gastrointestinal symptoms such as diarrhea and vomiting due to spoiled formula, the U.S. Food and Drug Administration said in a statement Friday.
Affected products were manufactured in Abbott’s Columbus, Ohio facility and include:
Find out what's happening in Across Pennsylvaniafor free with the latest updates from Patch.
- Similac® Pro-Total ComfortTM
- Similac® 360 Total Care®
- Similac 360 Total Care Sensitive
- Similac® Special Care® 24
- Similac Stage 1
- Similac® NeoSure®
- Similac Water (Sterilized)
- Pedialyte Electrolyte Solution
The recall does not include other liquid or powder formula brands, amino acid-based formulas, metabolic nutrition formulas or powder formula brands.
The entire recall amounts to less than a day’s worth of the total number of infant formula fed in the U.S. and isn’t expected to impact the nationwide infant formula supply, the FDA said. The manufacturer is currently continuing production of its Similac 2 fluid ounce/59 milliliter Ready-to-Feed liquid formula products for hospitals and healthcare offices on a different production line.
Find out what's happening in Across Pennsylvaniafor free with the latest updates from Patch.
"We take our responsibility to deliver high-quality products very seriously," said Joe Manning, Abbott’s executive vice president of nutritional products. "We internally identified the issue, are addressing it, and will work with our customers to minimize inconvenience and get them the products they need."
Click here to view a list of impacted lot numbers.
The products included in the recall were sent mostly to hospitals and doctors’ offices in the U.S., as well as Barbados, Bermuda, Colombia, the Dominican Republic, Haiti, Jamaica, St. Croix, St. Thomas, Canada, Curacao, Panama, and Trinidad and Tobago.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.